Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups.
about
The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessityEnvironmental, lifestyle, and anthropometric risk factors for differentiated thyroid cancer in cuba: a case-control studyDo US thyroid cancer incidence rates increase with socioeconomic status among people with health insurance? An observational study using SEER population-based dataClusters of adolescent and young adult thyroid cancer in Florida countiesContinued rapid increase in thyroid cancer incidence in california: trends by patient, tumor, and neighborhood characteristics.Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyrBMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review.Update on thyroid cancer treatment.Evolution of differentiated thyroid cancer: a decade of thyroidectomies in a single institution.Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.Feasibility study for the introduction of a new treatment method for benign thyroid nodules in a teaching and research hospital.Thyroid oncology.Thyroid cancer in Egypt: histopathological criteria, correlation with survival and oestrogen receptor protein expression.Disparities in the initial presentation of differentiated thyroid cancer in a large public hospital and adjoining university teaching hospitalA germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predispositionLong-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis.Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.The Bethesda System thyroid diagnostic categories in the African-American population in conjunction with surgical pathology follow-upGene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays.Benign and Malignant Thyroid Incidentalomas Are Rare in Routine Clinical Practice: A Review of 97,908 Imaging Studies.Long-term survival in young women: hazards and competing risks after thyroid cancer.SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the "volcanic factor"Risk factors associated with benign and malignant thyroid nodules in autoimmune thyroid diseasesAnaplastic Thyroid Carcinoma, Version 2.2015.Unbalanced estrogen metabolism in thyroid cancer.The changing face of thyroid cancer in a population-based cohort.Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer.Trends in thyroid cancer incidence in Texas from 1995 to 2008 by socioeconomic status and race/ethnicity.Targeted therapy with kinase inhibitors in aggressive endocrine tumors.Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells.Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.Daily urine iodine excretion while consuming a low-iodine diet in preparation for radioactive iodine therapy in a high iodine intake area.Proteomic Biomarkers for Bisphenol A-Early Exposure and Women's Thyroid Cancer.Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.Family history of malignant and benign thyroid diseases and risk of thyroid cancer: a population-based case-control study in New Caledonia.Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET.Demographic and socioeconomic factors predictive of compliance with American Thyroid Association guidelines for the treatment for advanced papillary thyroid carcinoma.
P2860
Q27021258-9CD4E69A-32AB-4B70-82B6-836DB4CE73A3Q28397288-5BE3A5A3-401C-4E8B-AF98-E8A82CCF0D1AQ31030724-C199A8A7-AAC4-4C03-A048-CA3FF41710F9Q33608827-5F004D7F-3D05-444A-BD44-A68B137CEAD4Q33807871-67E0068C-A4CC-4570-9E2A-0A5D5548E773Q33990855-B4DB2F35-77CA-44C6-BD00-8CF211BD83DDQ34140160-7288F71A-43B6-4828-9C2E-E158E7348D6BQ34310219-47F75B5B-36AF-4D9D-9F96-3A0137EF3EA8Q34472004-A2B4E043-FA4A-486F-8AB7-0E28D6043B7AQ34511758-AA12E2AD-6B4C-4ACC-9D5A-F30ED965A1B7Q35104726-15F66D96-EBDF-45D3-88B6-64C60A681399Q35170853-3CDEB1CA-B7B4-4A56-8ECA-1246A775E43DQ35326218-6F2FF2D0-DBB2-4A2D-910C-0BB0A62D4A86Q35541013-7D9934BA-23E3-46F1-8F77-BA49429BD77BQ35778526-E23CCC87-916E-46B1-B22B-C971A5152291Q35809227-B79AB2CC-B025-4F54-8605-1D9616A0FDBAQ35857918-108D2549-241B-415F-BA69-4F4D4D57A4DBQ35865327-FB5B74CC-BB38-4808-8888-969AC00878D0Q35890699-92EE25ED-7491-4138-BDDD-590FA455B48CQ35925897-2D8594C5-EBA7-4AB9-912D-066290CA26F8Q36029679-C034C98C-C6E1-4BB2-8DF8-1150A4602578Q36311582-BFF73960-65F8-4E43-AE66-AE6398CCB08FQ36817184-8CDE9B67-B099-4071-9229-BDFACC49FDA9Q36898834-A72C878A-2376-4518-BC35-5B7092D1059DQ36916106-5AA045A9-51B2-4641-A478-5F20EA92F6D1Q37179204-3F2DB63F-03F3-42A9-8AA1-F4B1203FA871Q37209923-55EB7972-A1FA-486B-8C83-5D2CFE4398EBQ37236271-B08FAB1E-0080-4CA6-B86C-D53815162307Q37403877-840CF90B-7325-404E-8720-2161C088B0E8Q37428978-DD7BE7A5-77E4-4DB0-BE81-57FBDB964E80Q37629952-0CD71C48-2D57-406C-A39F-4BCA6A6D0AEEQ38107011-3AC822ED-7253-432F-AB69-E744B319FA5AQ38446206-A0AA5DE0-9F5A-4B09-A2BC-3AC547BA9D47Q39227100-8E8D6B4C-458B-43ED-9ECD-5A80E05F7503Q39735240-464D1245-56CA-458D-B152-4D1CF51C005DQ40299522-CB1BABB5-3B83-4542-A226-659AD47FBC47Q41590745-78D5388F-F7C2-4833-A25E-8D7BEB8C206EQ44968002-E93775E1-056F-4AF8-A5ED-992939822713Q45012482-56B241E8-693F-42ED-BFFD-F3EB50B1750FQ45055603-5858E4F3-85B1-4D3E-B4F7-8942963EB4C9
P2860
Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Thyroid cancer incidence and s ...... results race/ethnicity groups.
@en
Thyroid cancer incidence and s ...... results race/ethnicity groups.
@nl
type
label
Thyroid cancer incidence and s ...... results race/ethnicity groups.
@en
Thyroid cancer incidence and s ...... results race/ethnicity groups.
@nl
prefLabel
Thyroid cancer incidence and s ...... results race/ethnicity groups.
@en
Thyroid cancer incidence and s ...... results race/ethnicity groups.
@nl
P2093
P356
P1433
P1476
Thyroid cancer incidence and s ...... results race/ethnicity groups.
@en
P2093
Daniel Branovan
Guo-Pei Yu
James Chun-Lun Li
Steven McCormick
Stimson P Schantz
P304
P356
10.1089/THY.2008.0281
P577
2010-05-01T00:00:00Z